Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Stoke Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 99 | 3 | 92 | −4 |
| Shares | 41.4M | 54.5K | 43.1M | +1.77M (+4.3%) |
| Value | $870.6M | $1.15M | $569.4M | −$300.0M (−34.5%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 1,013,071 | $13.8M | 0.01% |
| Granahan Investment Management Inc | 198,621 | $2.62M | 0.09% |
| Mirae Asset Global Investments Co., Ltd. | 80,798 | $1.07M | 0.00% |
| Altium Capital Management LP | 48,000 | $634.0K | 0.27% |
| PDT Partners, LLC | 23,670 | $313.0K | 0.03% |
| State Board of Administration of Florida Retirement System | 14,003 | $185.0K | 0.00% |
| Credit Suisse AG | 9,730 | $129.0K | 0.00% |
| Russell Investments Group, Ltd. | 2,170 | $28.0K | 0.00% |
| Group One Trading, L.P. | 200 | $3.00K | 0.00% |
| CWM, LLC | 21 | $0 | 0.00% |
Sold out (14)
Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| SG Americas Securities, LLC | 182,591 | $3.84M |
| Invesco Ltd. | 131,674 | $2.77M |
| Rafferty Asset Management, LLC | 62,065 | $1.31M |
| UBS Group AG | 51,941 | $1.09M |
| Gsa Capital Partners LLP | 40,495 | $852.0K |
| Marshall Wace, LLP | 17,237 | $362.0K |
| Susquehanna International Group, LLP | 14,409 | $303.0K |
| Engineers Gate Manager LP | 9,958 | $210.0K |
| Quantbot Technologies LP | 4,300 | $90.0K |
| STRS Ohio | 3,500 | $73.0K |
| State of Wyoming | 869 | $18.0K |
| Quadrant Capital Group LLC | 113 | $2.00K |
| Lindbrook Capital, LLC | 101 | $2.00K |
| Captrust Financial Advisors | 68 | $1.00K |
Not filed for Q2 2022 yet (3)
Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 36,124 | $760.0K |
| Virginia Retirement Systems Et Al | 15,300 | $322.0K |
| Amalgamated Financial Corp. | 3,118 | $66.0K |